Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $43.33 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $26.06 | 2 | $0 (2017) |
| Indivior Inc. | $17.27 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $43.33 | 3 | Teva Pharmaceuticals USA, Inc. ($26.06) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/27/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | Cash or cash equivalent | $17.27 | General |
| Category: OUD | ||||||
| 01/09/2017 | Teva Pharmaceuticals USA, Inc. | PROAIR (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Respiratory | ||||||
| 01/09/2017 | Teva Pharmaceuticals USA, Inc. | PROAIR (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 830 | 874 | $149,440 | $56,143 |
| 2022 | 12 | 1,004 | 1,070 | $179,065 | $75,804 |
| 2021 | 12 | 984 | 996 | $198,066 | $83,908 |
| 2020 | 16 | 1,087 | 1,190 | $215,886 | $71,639 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 355 | 363 | $74,340 | $29,836 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 59 | $17,700 | $6,932 | 39.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 69 | 69 | $20,838 | $6,732 | 32.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 160 | 162 | $16,100 | $5,574 | 34.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $8,244 | $2,640 | 32.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 27 | $3,321 | $1,561 | 47.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 31 | 62 | $1,860 | $1,006 | 54.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 23 | 23 | $3,450 | $697.36 | 20.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 22 | 22 | $2,420 | $597.11 | 24.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 25 | 26 | $780.00 | $421.20 | 54.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 42 | 43 | $387.00 | $146.63 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 281 | 290 | $59,799 | $28,166 | 47.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 129 | 129 | $38,956 | $15,881 | 40.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 279 | 287 | $28,600 | $9,956 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 62 | $18,600 | $8,112 | 43.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $14,656 | $5,143 | 35.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 58 | 58 | $7,311 | $3,789 | 51.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 20 | 20 | $4,200 | $1,749 | 41.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 50 | 99 | $2,970 | $1,613 | 54.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 18 | 18 | $1,980 | $485.34 | 24.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 24 | 24 | $720.00 | $391.08 | 54.3% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 11 | 11 | $913.00 | $381.27 | 41.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 40 | 40 | $360.00 | $137.42 | 38.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 143 | 147 | $45,943 | $21,403 | 46.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 176 | 178 | $37,591 | $17,778 | 47.3% |
About Dr. John Shallat, MD
Dr. John Shallat, MD is a Emergency Medicine healthcare provider based in Deer Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1538379599.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Shallat, MD has received a total of $43.33 in payments from pharmaceutical and medical device companies, with $43.33 received in 2017. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($43.33).
As a Medicare-enrolled provider, Shallat has provided services to 3,905 Medicare beneficiaries, totaling 4,130 services with total Medicare billing of $287,493. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Deer Park, NY
- Active Since 05/22/2007
- Last Updated 12/06/2019
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538379599
Products in Payments
- PROAIR (Drug) $26.06
- SUBOXONE SUBLINGUAL FILM (Drug) $17.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.